Hybrid STTR Intervention for Heterosexuals: Anonymous Testing and Confidential Care Linkage

NACompletedINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

January 31, 2016

Study Completion Date

December 31, 2016

Conditions
HIV/AIDS
Interventions
BEHAVIORAL

Seek and Test Phase

The primary endpoint for this phase is the proportion of newly identified HIV infections of the RDS-ASTN intervention. Components for eligible and willing participants are a computerized baseline interview, counseling session, blood draw for HIV testing, HIV pre-test counseling, use of blood samples for clinical lab tests if found to be HIV infected, semi-structured interviews (if selected), the opportunity to recruit peers for the study, and the post-test counseling session.

BEHAVIORAL

Treat and Retain Phase

The primary endpoints for this phase are: proportion linked to care within three months and time to the HIV care appointment. Participants with HIV infection who are interested in participating will be enrolled in this phase and navigated to HIV primary care over three months. Components are the locator form, patient navigation and support contacts, medical report form, follow-up contacts to update locator information, semi-structured interviews, follow-up interview, and blood draw for clinical lab testing.

Trial Locations (1)

10003

New York University College of Nursing, New York

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

New York University

OTHER

NCT02421159 - Hybrid STTR Intervention for Heterosexuals: Anonymous Testing and Confidential Care Linkage | Biotech Hunter | Biotech Hunter